Brief Introduction of CAR-T Cell Therapy Kymriah (Tisagenlecleucel)
Brief Introduction of CAR-T Cell Therapy Kymriah (Tisagenlecleucel) Kymriah is a CD19-directed genetically modified autologous T-cell immunocellular therapy, in which the CD19 chimeric antigen rece...